Dr Reddy’s terminates its India agreement with Novartis following a change in ownership, according to the report. The move ends the company’s existing arrangement that covered the promotion, distribution and sale of certain specified products in India.
The agreement previously granted Dr Reddy’s an exclusive, non-transferable right for the defined product portfolio. NDTV’s account focuses on the contractual termination linked to the ownership change, describing the scope of rights Dr Reddy’s held under the deal. The available information does not add details on the ownership change itself, the timing of the termination, or the specific products affected.
Across the provided material, the core point is the same: the agreement is terminated by Dr Reddy’s after an ownership change, and the termination follows the terms tied to Dr Reddy’s exclusive distribution and promotion rights for certain products.
